4.6 Review

Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients

Sherko Kuemmel et al.

Summary: The study demonstrates the feasibility of TAD in a real-world cohort of breast cancer patients, which is of great importance for the de-escalation of surgical strategies.

ANNALS OF SURGERY (2022)

Article Oncology

Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer

Stephanie M. Wong et al.

Summary: This study demonstrates that sentinel lymph node biopsy alone for patients who convert to pathologic node-negativity after neoadjuvant chemotherapy is associated with low short-term axillary recurrence rates. Additional follow-up data from prospective clinical trials are needed to confirm long-term oncologic safety and optimal local therapy recommendations.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients

Amit Goyal et al.

Summary: The study found that marking the axillary node with carbon dye and successfully identifying it intra-operatively is feasible, providing important implications for breast cancer patients.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Article Oncology

Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up

Sabrina Kahler-Ribeiro-Fontana et al.

Summary: This study evaluated the outcomes of patients undergoing NAT who remained or converted to cN0 and received SNB, showing a high overall survival rate after 10-year follow-up. The use of standard SNB in cN1/2 patients who become cN0 after NAT was deemed acceptable and did not result in worse outcomes.
Review Surgery

Diagnostic Performance of Noninvasive Imaging for Assessment of Axillary Response After Neoadjuvant Systemic Therapy in Clinically Node-positive Breast Cancer A Systematic Review and Meta-analysis

Sanaz Samiei et al.

Summary: The diagnostic performance of current noninvasive imaging modalities is limited in accurately assessing axillary response after NST in clinically node-positive breast cancer patients. The overall axillary pathologic complete response rate was found to be 39.5%, with different imaging modalities showing varying levels of sensitivity, specificity, PPV, and NPV.

ANNALS OF SURGERY (2021)

Review Oncology

Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox

Peter Dubsky et al.

Summary: An international consortium was established to provide clinical guidance and tools for the technical management of patients with early-stage breast cancer through discussions and consensus meetings. During the meeting, 42% of statements reached a consensus, 38% were supported by the majority, and 21% did not reach a decision.

LANCET ONCOLOGY (2021)

Article Obstetrics & Gynecology

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

Michael Friedrich et al.

Summary: The evolution of surgical procedures in breast cancer treatment focuses on optimizing systemic therapy and surgical methods, especially as neoadjuvant chemotherapy becomes increasingly important. Targeted axillary dissection and other methods aim to reduce the false negative rate in surgical axillary staging.

GEBURTSHILFE UND FRAUENHEILKUNDE (2021)

Article Oncology

Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer

Antonio Mariscal Martinez et al.

Summary: The use of magnetic seeds for preoperative localization and surgical dissection of metastatic axillary lymph nodes in breast cancer patients after neoadjuvant chemotherapy is safe and effective with a success rate of 100%. Additionally, targeted axillary dissection (TAD) reduces the rate of false negatives associated with sentinel lymph node biopsy alone.

SURGICAL ONCOLOGY-OXFORD (2021)

Article Oncology

Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event

Andrea Barrio et al.

Summary: This study examined nodal recurrence rates in patients with clinically node-positive cancer treated with sentinel lymph node biopsy after neoadjuvant chemotherapy, showing low rates of axillary failure at a median follow-up of 40 months, supporting potential omission of axillary lymph node dissection in patients achieving nodal pathologic complete response with SLNB alone.

JAMA ONCOLOGY (2021)

Article Multidisciplinary Sciences

Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy

Jung Whan Chun et al.

Summary: This study analyzed the long-term outcomes of patients with residual N1 nodal disease following neoadjuvant chemotherapy for breast cancer and found that omission of axillary lymph node dissection using propensity score matching was oncologically safe. No significant differences in axillary recurrence-free survival, distant metastasis-free survival, overall survival, and breast cancer-free survival were observed between SLNB only group and ALND group after propensity score matching.

SCIENTIFIC REPORTS (2021)

Review Oncology

Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study

Maggie Banys-Paluchowski et al.

Summary: This review discusses the uncertainty surrounding the optimal axillary staging surgery for breast cancer patients with lymph node metastasis post-neoadjuvant chemotherapy. Various surgical strategies have been investigated, but questions regarding oncological safety and optimal marking techniques remain unanswered. The multinational prospective cohort study AXSANA aims to address these knowledge gaps and recruit 3000 patients in 20 countries.

CANCERS (2021)

Article Oncology

The applicability of Magseed? for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy

R. Reitsamer et al.

Summary: Magseed (R) is a reliable and feasible marker for identifying TLNs in breast cancer patients, significantly improving the identification rate of sentinel lymph node biopsy.

BREAST (2021)

Review Oncology

St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer

Christoph Thomssen et al.

Summary: Due to the COVID-19 pandemic, the 2021 St. Gallen/Vienna Consensus Conference on Early Breast Cancer Treatment Standards had to be held virtually, where organizers successfully managed to convene global contributors, leading to well-received scientific discussions with over 3,400 participants from 100+ countries. The virtual format introduced new elements such as audience-suggested Consensus questions and live audience interaction, doubling discussion time across different time zones.

BREAST CARE (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Axillary Nodal Evaluation in Breast Cancer: State of the Art

Jung Min Chang et al.

RADIOLOGY (2020)

Review Medicine, Research & Experimental

Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis

Zhen-Yu Li et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Review Oncology

Axillary surgery in breast cancer: An updated historical perspective

Francesca Magnoni et al.

SEMINARS IN ONCOLOGY (2020)

Article Multidisciplinary Sciences

Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread

Qiaoli Ma et al.

SCIENCE ADVANCES (2018)

Article Public, Environmental & Occupational Health

Metaprop: a Stata command to perform meta-analysis of binomial data

Victoria N. Nyaga et al.

ARCHIVES OF PUBLIC HEALTH (2014)

Article Medicine, General & Internal

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial

Judy C. Boughey et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)